Surrozen Appoints Charles Williams as Chief Financial Officer Portfolio News / By Karina Tin October 30, 2020
Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial Results Portfolio News / By Karina Tin October 29, 2020
Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers Portfolio News / By Karina Tin October 24, 2020
NGM Expands Oncology Portfolio with First Immuno-Oncology Development Candidate, NGM707, a Novel Dual Antagonist Antibody Inhibiting ILT2 and ILT4 Portfolio News / By Karina Tin October 19, 2020
ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive License to Brain Penetrant EGFR/HER2 Exon 20 Inhibitor Program Portfolio News / By Karina Tin October 19, 2020
eFFECTOR Appoints Premal Patel, M.D., Ph.D., as Chief Medical Officer Portfolio News / By Karina Tin October 15, 2020
Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update Portfolio News / By Karina Tin October 14, 2020
A2 Biotherapeutics Closes $71.5M Series B to Begin Clinical Development of its Potentially Transformative Selective Tumor Cell Therapeutics Portfolio News / By Karina Tin October 6, 2020
Arcus Biosciences: Jennifer Jarrett Returns as Chief Operating Officer Portfolio News / By Karina Tin October 1, 2020
